Description
JH-II-127 is a selective inhibitor of leucine-rich repeat kinase 2 (LRRK2), a potential therapeutic target for neurodegenerative disease. It inhibits phosphorylation of Ser910 and Ser935 in both wild-type LRRK2 and the G2019S mutant.
| Product Unit Size | Cost | Quantity | Stock |
|---|
JH-II-127 is a selective inhibitor of leucine-rich repeat kinase 2 (LRRK2), a potential therapeutic target for neurodegenerative disease. It inhibits phosphorylation of Ser910 and Ser935 in both wild-type LRRK2 and the G2019S mutant.
| Cas No. | 1700693-08-8 |
|---|---|
| Purity | ≥98% |
| Formula | C19H21ClN6O3 |
| Formula Wt. | 416.87 |
| IUPAC Name | (4-{[5-Chloro-4-(methylamino)-3H-pyrrolo[2,3-d]pyrimidin-2-yl]amino}-3-methoxyphenyl)(4-morpholinyl)methanone |
| Synonym | Pyrrolopyrimidine |
| Solubility | DMSO |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Hatcher J., Zhang J., et al. Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 Inhibitor. ACS Med Chem Lett. 6(5):584-9 (2015). PMID: 26005538.
Mycotoxin derivative; actin polymerization inhi...
ET-A/B antagonist.
mTOR activator.
NSAID; CB1 agonist, COX-2 inhibitor.
Endogenous cardiomodulatory peptide; NPR-A agon...
Endogenous purine derivative of xanthine.
Diarylether; bacterial ENR binder, fatty acid s...
Cephalotaxine alkaloid originally found in Ceph...
VEGFR, PDGFR, c-Kit, RET inhibitor.
Peptide; NK2 antagonist.
PAK4 inhibitor.
Pheniramine derivative; histamine H1 and mAChR ...
mAChR agonist, selective for M2.
β-lactam cephalosporin; penicillin binding pro...
Negative control for PKC activation.
Thienylbutyl ITC analog.
Macrolide; protein translation inhibitor.
Diarylheptanoid found in Zingiberaceae.
Inhibitor of Akt.
c-Raf inhibitor.